From: Impact of parathyroidectomy on left ventricular function in end stage renal disease patients
CHARACTERISTIC | NUMBER |
---|---|
Sex | |
Male | 81(60.0%) |
Female | 54 (40.0%) |
Age | 45.60 ± 1.0 year |
Dialysis duration | 6.45 (5.0,9.0) year |
Dialysis modality | |
PD | 12 (8.9%) |
HD | 121 (89.6%) |
ESRD without dialysis | 2 (1.5%) |
Primary disease | |
CGN | 108 (80%) |
Polycystic kidney | 10 (7.4%) |
Hypertensive nephropathy | 5 (3.7%) |
Diabetic nephropathy | 4 (3.0%) |
Others | 8 (5.9%) |
The number of parathyroid gland | |
<4 | 16 (11.9%) |
≥ 4 | 119 (88.1%) |
Blood pressure | |
Pre-PTX systolic pressure (mmHg) | 139.4 ± 22.8 |
Pre-PTX diastolic pressure (mmHg) | 88.6 ± 15.4 |
1-year post-PTX systolic pressure (mmHg) | 144.5 ± 23.5 |
1-year post-PTX diastolic pressure (mmHg) | 80.1 ± 13.3 |
cardiovascular drugs used during the follow-up | |
ACEI | 5 (3.7%) |
ARBs | 30 (22.2%) |
calcium blockers | 50 (37.0%) |
cardiotonics | 1 (0.7%) |
β-blockers | 48 (35.6%) |
isosorbide mononitrate | 11 (8.1%) |
trimetazidine | 8 (5.9%) |